A

    Actinium Pharmaceuticals Inc (ATNM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $1.01
    +0.01 (+1.00%)

    Market Cap: $31.69M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    73%(29/40)
    Avg Surprise
    +21.36%
    Streak
    2 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.26
    Range$-0.27 - $-0.24
    2 analysts
    EPS Revisions
    2
    0
    7d
    2
    0
    30d
    EPS Estimate Drift
    90d ago$-0.23+7.8%
    60d ago$-0.24+5.9%
    30d ago$-0.24+5.9%
    7d ago$-0.24+5.9%
    Current$-0.26
    Revenue Consensus
    $0
    Range$0 - $0
    3 analysts
    Dec 31, 2026
    EPS Consensus$0.81
    Range$0.80 - $0.83
    2 analysts
    Revenue Consensus
    $12M
    Range$0 - $35M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.81---
    Sep 26EST
    		-$-0.26---
    Jun 26
    		$0.89$-0.20+545.00%Beat+504.5%
    Mar 26
    		$-0.18$-0.22+18.18%Beat+64.7%
    Dec 25
    		$-0.19$-0.18-5.78%Miss+9.3%
    Sep 25
    		$-0.16$-0.32+50.00%Beat+56.8%
    Jun 25
    		$-0.22$-0.35+37.14%Beat+42.1%
    Mar 25
    		$-0.51$-0.28-82.14%Miss-64.5%
    Dec 24
    		$-0.21$-0.39+46.15%Beat+36.4%
    Sep 24
    		$-0.37$-0.37+0.00%Beat+24.5%
    Jun 24
    		$-0.38$-0.40+5.00%Beat+34.5%
    Mar 24
    		$-0.31$-0.52+40.38%Beat+27.9%
    Dec 23
    		$-0.33$-0.54+38.89%Beat+23.3%
    Sep 23
    		$-0.49$-0.57+14.04%Beat-28.9%
    Jun 23
    		$-0.58$-0.49-18.37%Miss-75.8%
    Mar 23
    		$-0.43$-0.43+0.00%Beat-87.0%
    Dec 22
    		$-0.43$-0.35-22.86%Miss-19.4%
    Sep 22
    		$-0.38$-0.31-22.58%Miss-26.7%
    Jun 22
    		$-0.33$-0.23-43.48%Miss-32.0%
    Mar 22
    		$-0.23$-0.31+25.81%Beat+20.7%
    Dec 21
    		$-0.36$-0.30-20.00%Miss+2.7%
    Sep 21
    		$-0.30$-0.28-7.14%Miss+16.7%
    Jun 21
    		$-0.25$-0.29+13.79%Beat+39.0%
    Mar 21
    		$-0.29$-0.34+14.71%Beat+67.8%
    Dec 20
    		$-0.37$-0.37+0.00%Beat+58.9%
    Sep 20
    		$-0.36$-0.46+21.74%Beat+70.0%
    Jun 20
    		$-0.41$-0.40-2.50%Miss+54.4%
    Mar 20
    		$-0.90$-1.20+25.00%Beat+40.0%
    Dec 19
    		$-0.90$-1.20+25.00%Beat+40.0%
    Sep 19
    		$-1.20$-1.20+0.00%Beat+33.3%
    Jun 19
    		$-0.90$-1.50+40.00%Beat+25.0%
    Mar 19
    		$-1.50$-1.70+11.76%Beat+28.6%
    Dec 18
    		$-1.50$-1.80+16.67%Beat+16.7%
    Sep 18
    		$-1.80$-1.35-33.33%Miss+33.3%
    Jun 18
    		$-1.20$-1.90+36.84%Beat+66.7%
    Mar 18
    		$-2.10$-2.70+22.22%Beat+50.0%
    Dec 17
    		$-1.80$-2.62+31.30%Beat+50.0%
    Sep 17
    		$-2.70$-2.70+0.00%Beat+35.7%
    Jun 17
    		$-3.60$-4.05+11.11%Beat-
    Mar 17
    		$-4.20$-3.90-7.69%Miss-
    Dec 16
    		$-3.60$-4.20+14.29%Beat-
    Sep 16
    		$-4.20$-4.95+15.15%Beat-

    Key Metrics

    Valuation
    P/E Ratio2.81EV/EBITDA0.00x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin32.20%Operating Margin78.80%
    ROE45.90%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio4.08xQuick Ratio4.08x
    Trading Statistics
    Beta0.02Avg Volume176.19K
    52-Week High$1.7852-Week Low$0.73

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.06
    SMA 20$0.95
    SMA 50$0.94
    SMA 200$1.17
    EMA 10$1.02
    EMA 20$0.99
    EMA 50$0.98
    EMA 200$1.14

    MACD

    Line: 0.04Signal: 0.03Hist: 0.01

    ADX

    ADX: 28.3+DI: 21.9-DI: 22.4

    Aroon & PSAR

    Aroon Up72.0
    Aroon Down32.0
    PSAR$1.14

    Bollinger Bands

    Upper Band$1.22
    Lower Band$0.67
    %B Position5790%(Upper)
    Band Width0.61

    RSI (14-Day)

    Neutral
    54.3

    Momentum Oscillators

    Stoch %K62.9
    Stoch %D68.9
    Williams %R-36.9
    ROC (10d)-2.9%
    Momentum-0.03
    CCI (20d)28.2
    MFI (14d)71.8

    Volatility Measures

    ATR (14d)$0.06(6.1%)
    StdDev (20d)0.14
    Hist Vol87.4%(High)

    Volume Flow

    VWAP$1.00
    OBV12.9M
    AD Line-23.7M
    CMF (20d)-0.100

    Volume Metrics

    Avg Vol (20d)190.7K
    Vol Ratio0.6x
    VWMA (20d)$0.95

    Pivot Points

    R3$1.08
    R2$1.07
    R1$1.03
    Pivot Point$1.02
    S1$0.98
    S2$0.97
    S3$0.93

    Advanced Oscillators

    TSI17.45
    Ultimate Osc40.5
    KST177.28

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$35.00M$0$0$90,000$0$0$810,000$0$0$0$81,000$0
    Cost of Revenue$0$0$-615,000$0$0$0$204,000$0$0$0$199,000$0
    Gross Profit$35.00M$0$615,000$90,000$0$0$-204,000$0$0$0$81,000$0
    Operating Expenses$7.43M$5.90M$6.41M$5.78M$7.50M$16.64M$7.50M$12.60M$12.42M$9.60M$10.42M$14.35M
    R&D$5.38M$4.20M$4.30M$4.25M$4.88M$7.70M$4.81M$9.77M$8.82M$6.63M$8.12M$11.62M
    SG&A$2.06M$1.70M$2.12M$1.53M$2.62M$8.94M$2.69M$2.83M$3.59M$2.96M$2.31M$2.73M
    Operating Income$27.57M$-5,903,000$-6,414,000$-5,692,000$-7,503,000$-16,638,000$-7,505,000$-12,601,000$-12,418,000$-9,597,000$-10,343,000$-14,351,000
    Interest Income$336,000$381,000$474,000$561,000$625,000$700,000$853,000$1.03M$1.06M$927,000$0$1.07M
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$27.90M$-5,522,000$-5,940,000$-5,131,000$-6,878,000$-15,938,000$-6,652,000$-11,568,000$-11,353,000$-8,670,000$-9,324,000$-13,276,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$27.90M$-5,522,000$-5,940,000$-5,131,000$-6,878,000$-15,938,000$-6,652,000$-11,568,000$-11,353,000$-8,670,000$-9,324,000$-13,276,000
    EBITDA$28.00M$-5,683,000$-6,856,000$-5,486,000$-7,141,000$-16,433,000$-7,915,000$-12,399,000$-12,229,000$-9,381,000$-10,727,000$-14,151,000
    EBIT$27.57M$-5,903,000$-6,414,000$-5,692,000$-7,503,000$-16,638,000$-7,505,000$-12,601,000$-12,418,000$-9,597,000$-10,343,000$-14,351,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ATNM

    News

    ETFs Investing in Actinium Pharmaceuticals, Inc. Stocks

    This article lists ETFs that hold Actinium Pharmaceuticals, Inc. (ATNM) stocks, providing financial details for one such fund, the BUSM EA Bridgeway Ultra-Small Company Market ETF. It highlights how these funds make investing in stocks more accessible while potentially offering lower risk. The information includes market value, weight, issuer, management style, expense ratio, AUM, price, change, relative volume, and 3-year NAV total return for the listed ETF.

    TradingView•8/19/26•
    Somewhat-Bullish

    Form 8K Actinium Pharmaceuticals Inc For: 14 August By Investing.com

    This article reports on the filing of a Form 8K by Actinium Pharmaceuticals Inc. on August 14. The financial document is related to market activities and is published on Investing.com.

    Investing.com Nigeria•8/14/26•
    Neutral

    Form 8K Actinium Pharmaceuticals Inc For: 14 August By Investing.com

    This article announces that Actinium Pharmaceuticals Inc. filed a Form 8K on August 14. The filing is available through Investing.com, a financial markets platform. The document pertains to the company's financial and operational activities, indicating a routine disclosure required by the SEC.

    Investing.com Canada•8/14/26•
    Neutral

    Actinium Pharmaceuticals, Inc. (Delaware) Revenue Breakdown – AMEX:ATNM

    Actinium Pharmaceuticals, Inc. (Delaware) (AMEX:ATNM) generated $55,000 USD in total revenue last year. Their top-performing segment was Radiotherapies, which contributed $90,000 USD, an increase from $81,000 USD the previous year. The United States was the primary regional contributor, also accounting for $90,000 USD of the revenue.

    TradingView•8/1/26•
    Neutral

    Actinium Pharmaceuticals Inc (ATNM) Valuation: PE, PB & Fair Value Analysis

    This article provides a valuation analysis of Actinium Pharmaceuticals Inc (ATNM) as of July 29, 2026. The company currently holds a valuation score of 7.46 within the Biotechnology & Medical Research industry, with a P/E ratio of -1.11. Key metrics like P/B, P/S, and P/CF ratios have not been disclosed by the company.

    TradingKey•7/29/26•
    Neutral

    Frequently Asked Questions About ATNM

    Does ATNM pay dividends?
    Actinium Pharmaceuticals Inc (ATNM) does not currently pay a regular dividend.
    What is ATNM's P/E ratio?
    Actinium Pharmaceuticals Inc has a price-to-earnings (P/E) ratio of 2.81.
    What is ATNM's market cap?
    Actinium Pharmaceuticals Inc (ATNM) has a market capitalization of $31.69M with a current stock price of $1.01.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In